REPEATED TREATMENT WITH S. AUREUS SUPERANTIGENS EXPANDS THE SURVIVAL RATE OF EHRLICH ASCITES TUMOR BEARING MICE

References

• Marrack P., Kappler J. The Staphylococcal Enterotoxins and Their Relatives. Science 1990; 248: 705–711
   PubMed Web of Science ®Google Scholar
• Fraser J.D. High-Affinity Binding of Staphylococcal Enterotoxin A and B to HLA-DR. Nature (Lond.) 1989; 339: 221–223
   PubMed Web of Science ®Google Scholar
• Fischer H., Dohlsten M., Andersson U., Hedlund G., Ericsson P., Hansson J., Sjögren H.O. Production of TNF-alpha and TNF-beta by Staphylococcal Enterotoxin A Activated Human T Cells. J. Immunol. 1990; 144: 4663–4669
   PubMed Web of Science ®Google Scholar
• Johnson H.M., Russel J.K., Pontzer C.H. Staphylococcal Enterotoxins Microbial Superantigens. FASEB. J. 1991; 5(12)2706–12
   PubMed Web of Science ®Google Scholar
• Krakauer T. Differential Inhibitory Effects of IL-4 and Dexamethasone on Staphylococcal Enterotoxin-Induced Cytokine Production and T Cell Activation. J. Leukoc. Biol. 1995; 57(3)450–4
   PubMed Web of Science ®Google Scholar
• Bjork L., Anderson J., Ceska M., Anderson U. Endotoxin and Staphylococcus aureus Enterotoxin-A Induced Different Patterns of Cytokines. Cytokine 1992; 4: 513–519
   PubMed Web of Science ®Google Scholar
• Prospisil R., Mage R.G. CD5 and Other Superantigens as ‘Tickles’ of the B-Cell Receptor. Immunol. Today. 1998; 19(3)106–8
   Google Scholar
• Silverman G.J. vivo Consequences of B Cell Superantigen Immunization. Ann. NY Acd, Sci. 1997; 815: 105–10
   PubMed Web of Science ®Google Scholar
• Schuurman R. K., Gelfand E. W., Dosch H.M. Polyclonal Activation of Human Lymphocytes vitro. I. Characterization of the Lymphocyte Response to a T Cell-Independent B Cell Mitogen. J. Immunol. 1980; 125: 820–26
   PubMed Web of Science ®Google Scholar
• Sinha P., Ghosh A.K., Das T., Sa G., Ray P. K. Protein-A of Staphylococcus aureus Evokes Th1 Type response in Mouse. Immunol. Lett. 1999; 67: 157–65
   PubMed Web of Science ®Google Scholar
• Goenka S., Das T., Sa G., Ray P.K. Protein-A Induces NO Production; Involvement of Tyrosine Kinase, Phospholipase C and Protein Kinase C. Biochem. Biophy. Res. Commun. 1998; 250: 425–9
   PubMed Web of Science ®Google Scholar
• Ray P.K., Dohadwala M., Bandyopadhyay S., Canchanapan P., McLaughlin D. Rescue of Rats from Large Dose Cyclophosphamide Toxicity Using Protein-A. Cancer Chemo. Pharmacol. 1985; 4: 59
   Google Scholar
• Bansal M.R., Khanna D., Gupta R.G., Jain P.K. Histopathology Study of Rat Memory Adenocarcinoma After Protein-A Administrations. Environ. Pathol. Toxicol. Oncol. 1989; 9: 343
   Google Scholar
• Solal-Celigny P., Simieon J., Herrera A., Boivin P. Cancer Treatment with Staphylococcus Protein-A. Bimed. Pharmacother. 1985; 177: 186
   Google Scholar
• Terman D.S. Staphylococcus Protein-A in Neoplastic Disease. J. Biol. Response Modif. 1984; 3: 316–24
   Google Scholar
• Rosendahl A., Kristensson K., Carlsson M., Skartvted N.J., Riesbeck K., Sogaard M., Dohlsten M. Long-term Survival and Complete Cures of B16 Melanoma-carrying Animals After Therapy with Tumor Targeted IL-2 and SEA. Int. J. Cancer. 1999; 81: 156–163
   PubMed Web of Science ®Google Scholar
• Schad E.M., Zaitseva I., Zaitsev V.N., Dohlsten M., Kalland T., Schlievert P.N., Ohlendrof D.H., Svensson L.A. Crystal Structure of the Superantigen Staphylococcal Enterotoxin Type-A. EMBO J. 1995; 14(14)3292–301
   PubMed Web of Science ®Google Scholar
• Forsgren A., Sjöquist J. “Protein-A” From S. aureus I Pseudoimmune Reaction with Human gamma-globulin. J. Immunol. 1966; 97: 822–7
   PubMed Web of Science ®Google Scholar
• Deisenhofer J. Crystallographic Refinement and Atomic Models of a Human Fc Fragment and Its Complex with Fragment B of Protein-A From Staphylococcus aureus at 2.9 and 2.8 Å Resolution. Biochemistry 1981; 20: 2361–70
   PubMed Web of Science ®Google Scholar
• Inganas M., Johanson S.G. Influence of the Alternative Protein-A Interaction on the Precipitation Between Human Monoclonal Immunoglobulins and Protein-A from Staphylococcus aureus. Int. Arch. Allergy Appl. Immunol. 1981; 65: 91–101
   PubMedGoogle Scholar
• Romagnani S., Giudizi M.G., Prete G.D., Maggi E., Biaggioti R., Almerigogna F., Ricci M. Demonstration on Protein-A of Two Distinct Immunological Binding Sites and Their Role in the Mitogenic Activity of Staphylococcus aureus Cowan I on Human B-cells. J. Immunol. 1982; 129: 596–602
   PubMed Web of Science ®Google Scholar
• Kozlowski L.M., Li W., Goldschmidt M., Levinson A.I. vivo Inflammatory Response to a Prototypic B-cell Superantigen: Elicitation of an Arthus Reaction by Staphylococcal Protein-A. J. Immunol. 1998; 160: 5246–52
   PubMed Web of Science ®Google Scholar
• Dohlsten M., Hedlund G., Åkerblom E., Lando P.A., Kalland T. Monoclonal Antibody-targeted Superantigens: A Different Class of Antitumor Agents. Proc. Natl. Acad. Sci. USA. 1991; 88: 9287–9291
   PubMed Web of Science ®Google Scholar
• Dohlsten M., Abrahmsen L., Bjork P., Lando P.A., Hedlund G., Forsberg G., Brodin T., Gascoigne N.R., Forberg C., Lind P., Kalland T. Monoclonal Antibody-Superantigen Fusion Proteins:bTumor-Specific agents for T-Cell Based Tumor Therapy. Proc. Natl. Sci, (Wash.) 1994; 91: 8945–8949
   PubMed Web of Science ®Google Scholar
• Dohlsten M., Hansson J., Ohlsson L., Litton M., Kalland T. Antibodi-targeted Superantigens Are Potent Inducers of Tumor Infiltrating T-lymphocytes In vivo. Proc. Natl. Sci, (Wash.) 1995; 92: 9791–9795
   PubMed Web of Science ®Google Scholar
• Kono K., Salazar-Onfray F., Petersson M., Hansson J., Masucci G., Wasserman K., Nakazawa T., Anderson P., Kiessing R. Hydrogen peroxide Secreted by Tumor Derived Macrophages Down-Modulates Signal-Transducing Zeta Molecules and Inhibits Tumor-Specific T-Cell and Natural Killer Cell Mediated Cytotoxicity. Eur. J. Immunol. 1996; 26: 1313
   Google Scholar
• Mondal T.K., Bhatta D., Ray P. K., Pal P. Synergestic Immunopotentiating Effects Induced by T-Cell and B-Cell Superantigen in Mice. Immunol. Invest. 2001; 30: 169–180
   PubMed Web of Science ®Google Scholar
• Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of Nitrate, Nitrite, [15N] Nitrate in Biological Fluids. Anl. Biochem. 1982; 126: 131–138
   PubMed Web of Science ®Google Scholar
• Yoo Y.C., Watanave S., Watanave R., Hata K.K., Shimazaki K., Azuma I. Bovine Lactoferrin and Lactoferricin, a Peptide Derived from Bovine Lactoferrin, Inhibit Tumor Metastasis in Mice. Jpn. J. Cancer Res. 1997; 88: 184–90
   PubMedGoogle Scholar
• Greenberg P. Adaptive T-cell Therapy of Tumor: Mechanisms Operative in the Recognition and Elimination of Tumor Cells. Adv. Immunol. 1991; 49: 281–355
   PubMed Web of Science ®Google Scholar
• Bennett S.;, Carbone F., Karamalis F., Miller J., Heath W. Induction of a CD8+ Cytotoxic T-lymphocyte Response by Cross-priming Requires Cognate CD4 Help. J. Exp.Med. 1997; 186: 65–70
   PubMed Web of Science ®Google Scholar
• Cardin R., Brooks J., Sarawar S., Doherty P. Progressive Loss of CD8+ T-cell Mediated Control of a Gamma-herpes Virus in the Absence of CD4+ T-cells. J. Exp. Med. 1996; 184: 863–71
   PubMed Web of Science ®Google Scholar
• Chouaib S., Branellec D., Buurman W.A. More Insights into the Complex Physiology of TNF. Immunol. Today 1991; 12(5)141–142
   Google Scholar
• Bonnem E.M., Oldham R.K. Gamma Interferon: Physiology and Potential Role in Cancer Therapy. J. Biol. Response Mod. 1987; 6: 275–301
   Google Scholar
• Simon P.L., Farrar J.J., Kind P.D. Biochemical Relationship Between Murine Immune Interferon and Killer Cells Helper Factor. J. Immunol. 1979; 122: 127
   Google Scholar
• Sayers T.J., Mason A.T., Ortaldo J. R. Regulation of Human Natural Killer Cells Activity by Interferon-γ Lack of a Role in Interleukin-2 Mediated Augmentation. J. Immunol. 1986; 136: 2176
   PubMed Web of Science ®Google Scholar
• Passina A., Bambrilla P., Villa S., Marocchi A., Mocarelli P. Factors Produced by Macrophages and Tumor Cells: Influence on the Granulocytic Precursor Cells (CFU-C) in Normal and Tumor Bearing Mice. J. Cancer Res. Clin. Oncol. 1982; 102: 235–244
   Google Scholar
• Valadares M.C., Kelin S.I., Zyngier S., Quiroz M.L. Growth and Differentiation of Bone Marrow Hemopoietic Cells in Mice Bearing Ehrlich Ascite Tumor and Treated with Dicyclopentadienildichlorotitanium (IV). Int. J. Immunopharmacol. 1998; 20: 573–81
   PubMed Web of Science ®Google Scholar
• Keller R., Geiges M., Keist R. L-arginine Dependent Reactive Nitrogen Intermediates as Mediators of Tumor Cell Killing by Activated Macrophages. Cancer Res. 1989; 50: 1421
   Google Scholar
• Stueher D.J., Nathan C.F. Nitric Oxide: A Macrophage Product Responsible for Cytostasis and Respiratory Inhibition in Tumor Target Cells. J. Exp. Med. 1989; 169: 1543
   Google Scholar
• Takanami I., Takeuchi K., Giga M. The Prognostic Value of Natural Killer Cell Infiltration in Resected Pulmonary Adenocarcinoma. J. Thorac. Cadiovasc. Sug. 2000; 121(6)1058–63
   Google Scholar
• Liew F. Y., Cox F. E. Nonspecific Defence Mechanisms: The Role of Nitric Oxide. Immunol. Today. 1991; 12(3)1721
   Google Scholar
• Stiles B.G., Bavari S., Krakuer T., Ulrich R.G. Toxicity of Staphylococcal Enterotoxins Potentiated by Lypopolysaccharide: Major Histocompatibility Complex Class II Molecule Dependency and Release. Infect. and Immun. 1993; 61(12)5333–5338
   Google Scholar
• Nakai S., Hirai Y. The Therapeutic Potential of Interleukin-1 beta in the Treatment of Chemotherapy or Radiation induced Myelosupression and in Tumor Therapy. Biotherapy 1989; 1: 339–354
   Google Scholar
• Nemunaitis J., Buckner C. D., Press O., Lileby K., Buhles B., Singer J. Phase 1 Trial with Interleukin-1β (IL-1β) in patients undergoing autologous bone marrow transplantation (ABMT) for Acute Myelogenous Leukemia (AML). Blood 1991; 78: 8
   Google Scholar